Video
Beyond the Data: AMUNDSEN
15:06
Gilles Montalescot sits down with Mamas Mamas to discuss the trial of PCSK9 inhibition with evolocumab in the cath lab before PCI, and why it makes sense to start early in lowering LDL for patients with acute MI.
Related News